Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy
Evaluating the Feasibility of a Nurse-Driven Telephone Triage Intervention for Cancer Patients Undergoing Chemotherapy in the Ambulatory Setting
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
PRIMARY OBJECTIVES:
I. To explore the feasibility of a proactive nurse-driven telephone triage intervention for patients with cancer receiving first-line chemotherapy in the ambulatory setting.
SECONDARY OBJECTIVES:
I. To explore the symptom experience of patients receiving a nurse-driven telephone triage intervention while receiving chemotherapy in the ambulatory setting.
II. To explore the satisfaction of patients receiving a nurse-driven telephone triage intervention while receiving chemotherapy in the ambulatory setting.
III. To explore the frequency of emergency room visits and hospital admissions for symptom management by patients receiving a nurse-driven telephone triage intervention while receiving chemotherapy in the ambulatory setting.
OUTLINE:
During standard of care chemotherapy, patients receive up to 18 telephone calls from a nurse using a standardized triage call script over 20 minutes.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- M D Anderson Cancer Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- English speaking
- Newly diagnosed patients with a breast, sarcoma, or head and neck cancer diagnosis preparing to undergo first-line, standard of care chemotherapy (patients with head and neck cancer may be undergoing concurrent first-line chemotherapy and radiation treatment)
- All chemotherapy treatment to be completed at the study institution
Exclusion Criteria:
- Patients who have received previous chemotherapy treatment for cancer
- Patients who will be receiving chemotherapy on research protocols
- Pregnant patients, as they may be on unique treatment protocols outside standard of care or have symptom needs that are beyond the scope of this intervention
- Patients who are unable to verbalize (e.g. due to tracheostomy)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Supportive Care (telephone intervention)
During standard of care chemotherapy, patients receive up to 18 telephone calls from a nurse using a standardized triage call script over 20 minutes.
|
Hjælpestudier
Modtag telefonopkald
Complete survey
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of completing nurse-driven telephone triage calls
Tidsramme: Up to 25 weeks
|
Completion is defined as the patient answering the call and completing the assessment; the target completion rate is set as 70%.
Completion of nurse-driven calls will be assessed separately by center (breast, sarcoma, head and neck) and globally across all centers.
The study will declare the intervention to be feasible within a center if the 90% confidence interval for completion rate is completely above 70% or contains 70%.
To calculate the confidence interval, the study will construct a generalized linear mixed model with only a term for intercept.
|
Up to 25 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Symptom experience
Tidsramme: Up to 25 weeks
|
Will be measured using the MD Anderson Symptom Inventory (MDASI).
This information will be summarized using graphical methods including box-plots and histograms, as well as summary statistics and 90% confidence intervals.
The MDASI will be assessed by center and time point, as well as by time point across all centers.
|
Up to 25 weeks
|
|
Patient Satisfaction
Tidsramme: Up to 25 weeks
|
This information will be summarized using graphical methods including box-plots and histograms, as well as summary statistics and 90% confidence intervals.
Satisfaction will be assessed by treatment group and by time point, as appropriate.
They will also be assessed by center and again across all centers.
|
Up to 25 weeks
|
|
Number of emergency room visits
Tidsramme: Up to 25 weeks
|
This information will be summarized using graphical methods including box-plots and histograms, as well as summary statistics and 90% confidence intervals.
Number of emergency room visits will be assessed by treatment group and by time point, as appropriate.
They will also be assessed by center and again across all centers.
|
Up to 25 weeks
|
|
Number of hospital admissions
Tidsramme: Up to 25 weeks
|
This information will be summarized using graphical methods including box-plots and histograms, as well as summary statistics and 90% confidence intervals.
Number of hospital admissions will be assessed by treatment group and by time point, as appropriate.
They will also be assessed by center and again across all centers.
|
Up to 25 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Colleen Jernigan, M.D. Anderson Cancer Center
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2016-0300 (Anden identifikator: M D Anderson Cancer Center)
- P30CA016672 (U.S. NIH-bevilling/kontrakt)
- NCI-2019-02651 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .